Direktorat Registrasi ObatValid

GEMCITABINE HYDROCHLORIDE

Claim this product
BPOM Number
GKL1522250344B1
Approved
12 May 2026
Expiry
30 October 2030
Form
SERBUK INJEKSI LIOFILISASI

About This Registration

GEMCITABINE HYDROCHLORIDE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1522250344B1. Its current registration status is Valid, with the licence valid until 30 October 2030. The product is registered to SANBE FARMA and manufactured by SANBE FARMA - INDONESIA. BPOM first approved this registration in April 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 1 VIAL @ 1000 MG
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

GEMCITABINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio
SANBE FARMA holds 554 BPOM registrations
Manufacturer Scale
SANBE FARMA - INDONESIA produces 488 registered products
Registration Age
Registered for 2 months
Update Status
Recently updated (66 days ago)

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1